A 28-year-old woman from rural India presents with dyspnea on exertion and orthopnea for 3 months. On examination, she has an opening snap, diastolic murmur at the apex, and signs of pulmonary edema. Chest X-ray shows cardiomegaly and pulmonary congestion. Echocardiography confirms mitral stenosis with a valve area of 1.2 cm². She is currently on diuretics and digoxin. What is the most appropriate next step in management?

Question

Accepted Answer

B. Refer for percutaneous mitral balloon valvotomy (PMBV). ## Clinical Context This patient has symptomatic mitral stenosis (MS) with hemodynamically significant stenosis (valve area 1.2 cm²; normal >4 cm²) causing pulmonary edema despite medical therapy. ## Indications for Percutaneous Mitral Balloon Valvotomy (PMBV) **Key Point:** PMBV is the procedure of choice for symptomatic mitral stenosis with favorable valve morphology and no contraindications. | Feature | Indication for PMBV | | --- | --- | | Symptoms | Symptomatic (NYHA II–IV) | | Valve area | <1.5 cm² | | Valve morphology | Pliable, non-calcified leaflets | | LA thrombus | Absent | | MR severity | Mild or none | | Atrial fibrillation | May be present | **High-Yield:** PMBV has superior outcomes to surgical mitral commissurotomy in suitable candidates and is the gold standard in India where rheumatic MS is endemic. ## Why PMBV is Next 1. **Symptomatic despite medical therapy** — diuretics and digoxin provide only symptomatic relief; they do not alter the structural stenosis. 2. **Hemodynamically significant stenosis** — valve area 1.2 cm² is well below the 1.5 cm² threshold for intervention. 3. **Likely favorable anatomy** — no mention of calcification, thrombus, or severe MR; typical of young Indian patients with rheumatic MS. 4. **Avoids surgery** — PMBV is less invasive than open mitral commissurotomy or valve replacement. **Clinical Pearl:** Opening snap and diastolic murmur indicate pliable leaflets—a favorable prognostic sign for PMBV success. ## Management Algorithm ```mermaid flowchart TD A[Symptomatic Mitral Stenosis]:::outcome --> B{Valve area < 1.5 cm²?}:::decision B -->|No| C[Continue medical management]:::action B -->|Yes| D{Favorable morphology?}:::decision D -->|No| E[Surgical commissurotomy or MVR]:::action D -->|Yes| F{LA thrombus?}:::decision F -->|Yes| G[Anticoagulate, then reassess]:::action F -->|No| H[PMBV]:::action H --> I[Symptom relief & improved hemodynamics]:::outcome ``` **Mnemonic:** **PMBV FIRST** — Pliable, Mitral, Balloon, Valvotomy = First-line for suitable MS. ![Rheumatic Heart Disease diagram](https://mmcphlazjonnzmdysowq.supabase.co/storage/v1/object/public/blog-images/explanation/2945.webp)

Answer

A. Increase the dose of diuretics and add a beta-blocker

Answer

C. Perform cardiac catheterization to assess coronary artery involvement

Answer

D. Start anticoagulation with warfarin and continue medical management

Explanation

Clinical Context

Indications for Percutaneous Mitral Balloon Valvotomy (PMBV)

Why PMBV is Next

Management Algorithm

Practice similar questions

Join our NEET PG community

Feature	Indication for PMBV
Symptoms	Symptomatic (NYHA II–IV)
Valve area	<1.5 cm²
Valve morphology	Pliable, non-calcified leaflets
LA thrombus	Absent
MR severity	Mild or none
Atrial fibrillation	May be present